SCHEMBL3863014

SCHEMBL3863014

O=C(O)c1ccc2[nH]c(-c3ccc(Cl)s3)nc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A2 P19784 1/20 0.49
▸ CSNK2B P67870 1/20 0.49
▸ CHEK2 O96017 5/20 0.48
▸ HDAC6 Q9UBN7 2/20 0.45
▸ KDM4E B2RXH2 3/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ HPGD P15428 2/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ KMT2A Q03164 2/20 0.43
▸ NR4A2 P43354 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ GLA P06280 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ PPARG P37231 1/20 0.43
▸ NCOA2 Q15596 1/20 0.43
▸ NCOA1 Q15788 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19223667 0.85 KDM4E (0.57) CHEK2HDAC6KDM4EALDH1A1SMN1; SMN2
SCHEMBL17941970 0.84 KDM4E (0.55) CSNK2A2CSNK2BCHEK2HDAC6KDM4E
SCHEMBL8346424 0.82 SIRT2 (0.55) KDM4EALDH1A1SMN1; SMN2HPGDNPC1
SCHEMBL828113 0.81 KDM4E (0.56) CHEK2KDM4EALDH1A1SMN1; SMN2HPGD
SCHEMBL3861744 0.81 F10 (0.47) KDM4EALDH1A1HPGDKMT2AMEN1
SCHEMBL4687144 0.81 F10 (0.40) CHEK2HDAC6KDM4EALDH1A1SMN1; SMN2
SCHEMBL7471440 0.80 CHEK2 (0.45) CHEK2HDAC6KDM4EALDH1A1SMN1; SMN2
SCHEMBL13759438 0.78 F10 (0.43) HDAC6F10
SCHEMBL8346713 0.78 F10 (0.47) HDAC6KDM4EALDH1A1SMN1; SMN2HPGD
SCHEMBL5177560 0.78 CHEK2 (0.51) CHEK2KDM4EALDH1A1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7566789-B2 Benzimidazole derivatives MERCK PATENT GMBH (DE) 2009-07-28 — — US disclosed
US-7566789-B2 Benzimidazole derivatives MERCK PATENT GMBH (DE) 2009-07-28 — — US disclosed
US-7566789-B2 Benzimidazole derivatives MERCK PATENT GMBH (DE) 2009-07-28 — — US disclosed
US-20050272740-A1 Benzimidazole derivatives MERCK PATENT GMBH (DE) 2005-12-08 — — US disclosed
CN-1674893-A Benzimidazole derivatives MERCK PATENT GMBH (DE) 2005-09-28 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272740-A1 Benzimidazole derivatives F12, F11, SERPINC1 CSNK2A2 2317/4885CSNK2B 2572/4885CHEK2 1681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback